Drug Trial Radar · NCT03572933
Study of Adjunctive Ganaxolone Treatment in Children and Young Adults With CDKL5 Deficiency Disorder
Last checked: Nov 19, 2026Latest source record: Apr 14, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
101
Actual
Start
Jun 30, 2018
Primary completion
Jul 31, 2020
Study completion May 28, 2021
Sponsor
- Lead sponsor
- Marinus PharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Jun 28, 2018
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years, up to 21 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A clinical study to evaluate the efficacy, safety, and tolerability of adjunctive ganaxolone therapy compared to placebo for the treatment of seizures in children and young adults with genetically confirmed CDKL5 gene mutation.
Conditions
- CDKL5 Deficiency Disorder
Interventions
ganaxoloneDrug
active drug
PlaceboDrug
inactive
Primary outcomes
What the sponsor says the trial is designed to measure.
- Summary of 28-day Seizure Frequency for Major Motor Seizure TypesTime frame: End of the double-blind 17 week treatment period
Locations
36 sites in 8 countries. Site status is shown where the registry gives one.
Marinus Research Site
Phoenix, Arizona
Marinus Research Site
Los Angeles, California
Marinus Research Site
Aurora, Colorado
Marinus Research Site
Gulf Breeze, Florida
Marinus Research Site
Orlando, Florida
Marinus Research Site
Norcross, Georgia
Marinus Research Site
Chicago, Illinois
Marinus Research Site
Iowa City, Iowa
Marinus Research Site
Boston, Massachusetts
Marinus Research Site
Rochester, Minnesota
Marinus Research Site
St Louis, Missouri
Marinus Research Site
Livingston, New Jersey
Marinus Research Site
Cleveland, Ohio
Marinus Research Site
Philadelphia, Pennsylvania
Marinus Research Site
Pittsburgh, Pennsylvania
Marinus Research Site
Fort Worth, Texas
Marinus Research Site
Houston, Texas
Marinus Research Site
Brisbane, Queensland, Australia
Marinus Research Site
Heidelberg, Victoria, Australia
Marinus Research Site
Melbourne, Victoria, Australia
Marinus Research Site
Paris, France
Marinus Research Site
Ramat Gan, Israel
Marinus Research Site
Florence, Italy
Marinus Research Site
Milan, Italy
Marinus Research Site
Pavia, Italy
Marinus Research Site
Roma, Italy
Marinus Research Site
Verona, Italy
Marinus Research Site
Bydgoszcz, Poland
Marinus Research Site
Krakow, Poland
Marinus Research Site
Moscow, Russia
Marinus Research Site
Nizhny Novgorod, Russia
Marinus Research Site
Novosibirsk, Russia
Marinus Research Site
Birmingham, United Kingdom
Marinus Research Site
Bristol, United Kingdom
Marinus Research Facility
Glasgow, United Kingdom
Marinus Research Site
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.